Brief: EQL Pharma Q3 EBIT SEK 14.8 Million
05/02/2025 06:00
Feb 05 (Reuters) - EQL Pharma Q3 adjusted free cash flow SEK 7.6 million. * Q3 EBIT margin 16% * Q3 revenue SEK 92.2 million
EQL — EQL Pharma AB News Story
0.000.00%
Last trade - 00:00- SEK670.32m
- SEK1.07bn
- SEK432.66m